Table 2 Outcomes results of the aspirin and non-aspirin therapy groups

Categorical

ICU mortality n (%)

32 (20.8)

95 (15.6)

1.42

0.91,2.22

0.12

1.18

0.69, 2.02

0.55

Hospital mortality n (%)

62 (40.3)

180 (29.6)

1.61

1.11,2.32

0.01

0.95

0.61, 1.50

0.82

Sepsis n (%)

56 (36.4)

256 (42.04)

0.79

0.55,1.36

0.20

1.18

0.76, 1.84

0.45

Severe sepsis n (%)

51 (33.1)

182 (29.9)

1.16

0.80,1.70

0.44

1.70

1.08, 2.70

0.02

28 day mortality n (%)

19 (30.7)

31 (17.4)

2.09

1.08,4.07

0.02

1.41

0.65, 3.05

0.39

180 day mortality n (%)

50 (34.1)

128 (22.7)

1.75

1.18, 2.60

0.005

0.72

0.43, 1.21

0.22

Continuous

point estimate

95 % CI

P value

point estimate

95 % CI

P value

MV duration (days)

11.17 ± 14.92

9.60 ± 9.05

1.58

−0.28, 3.44

0.09

2.7

0.51, 4.90

0.02

ICU LOS (days)

12.4 ± 15.2

10.8 ± 9.5

1.7

−0.27, 3.58

0.09

2.67

0.38,4.96

0.02

Hospital LOS (days)

65.6 ± 107.2

58.4 ± 81.7

7.22

−8.3, 22.7

0.36

12.5

−5.90, 30.96

0.18